Physicians' Academy for Cardiovascular Education

Covid-19

Overview of recent news and publications on COVID-19 and cardiovascular disease

Decrease in primary care visits, but increase in telemedicine during COVID-19 pandemic in USA

Literature - Oct. 13, 2020 - Alexander GC, et al. - JAMA Netw Open. 2020

Changes in the structure of primary care delivery, and differences in content of telemedicine visits vs. office-based visits were observed in the USA during the COVID-19 pandemic.

No clinical benefit from suspending ACEi/ARBs in hospitalized patients with COVID-19

3' education - Sep. 7, 2020 - Prof. Renato D. Lopes, MD, PhD
BRACE CORONA was a randomized trial that tested two strategies in hospitalized patients with COVID-19 who were on ACEi or ARBs: Temporarily suspending or continuing ACEi/ARBs. Prof. Lopes discusses the results.

ESC 2020 BRACE CORONA was a randomized trial that tested two strategies in hospitalized patients with COVID-19 who were on ACEi or ARBs: Temporarily suspending or continuing ACEi/ARBs. Prof. Lopes discusses the results.

Randomized trial on continuing versus suspending ACEi and ARBs in COVID-19

News - Sep. 1, 2020

ESC 2020 Suspension of ACEi/ARB therapy for 30 days did not impact the number of days alive and out of hospital at 30 days compared to continued use of these medications in COVID-19 patients.

Advantages of the digital 2020 ESC Congress

3' education - Sep. 1, 2020 - Prof. Barbara Casadei, MD
Although networking opportunities are poor during this year's ESC congress, there are plusses for a digital congress. Prof. Casadei lists some of them.

ESC 2020 Although networking opportunities are poor during this year's ESC congress, there are plusses for a digital congress. Prof. Casadei lists some of them.

Huge impact of COVID-19 outbreak on patients with diseases that can normally be treated

3' education - Aug. 30, 2020 - Prof. Barbara Casadei, MD
During the COVID-19 outbreak, some areas have seen an increase in excess mortality up to 40-50%, not due to COVID-19. Prof. Casadei strongly urgues that in the future physicians should save lives of patients they know how to save.

ESC 2020 During the COVID-19 outbreak, some areas have seen an increase in excess mortality up to 40-50%, not due to COVID-19. Prof. Casadei strongly urgues that in the future, physicians should save lives of patients they know how to save.

Cardiac abnormalities in recovered COVID-19 patients

3' education - July 29, 2020 - Prof. Rudolf de Boer, MD, PhD
Prof. De Boer discusses a recent paper in JAMA Cardiol on cardiac abnormalities detected by cardiovascular MRI in 100 patients who had proven COVID-19 around 2 months ago.

Prof. De Boer discusses a recent paper in JAMA Cardiol on cardiac abnormalities detected by cardiovascular MRI in 100 patients who had proven COVID-19 around 2 months ago.

Cardiac involvement and ongoing myocardial inflammation in recovered COVID-19 patients

Literature - July 28, 2020 - Puntmann VO et al., - JAMA Cardiol. 2020.

Cardiovascular MRI revealed cardiac involvement in 78% of patients and ongoing myocardial inflammation in 60% of patients in an unselected cohort of 100 patients who recently recovered from COVID-19.

Expert Position Paper on conducting HF clinical trials in the COVID-19 era

News - June 17, 2020

The Heart Failure Association (HFA) of the European Society of Cardiology (ESC) has published an expert consensus position paper on conducting clinical trials in HF during and after the COVID-19 pandemic.

Health professionals report decrease in STEMI admissions since COVID-19 outbreak

Literature - June 15, 2020 - Pessoa-Amorim G et al., - Eur Heart J Qual Care Clin Outcomes. 2020.

A survey conducted by the ESC among cardiologists and CV nurses revealed that 78.8% of responders perceived a decrease in STEMI admissions since the beginning of the COVID-19 outbreak.

Prevention and management of CVD in diabetes patients in the COVID-19 era

News - June 2, 2020

Members of the Diabetes and Cardiovascular Disease EASD Study Group have published a perspective on issues of CV risk management in diabetes patients during the COVID-19 pandemic.

Use of in-hospital anticoagulation and mortality in hospitalized COVID-19 patients

Literature - May 27, 2020 - Paranjpe I, et al. - J Am Coll Cardiol 2020

Survival was examined in a cohort of hospitalized COVID-19 patients in New York City, who were divided in those who received anticoagulation during hospital stay and those who did not.

High incidence of acute kidney injury in hospitalized patients with COVID-19

Literature - May 26, 2020 - Hirsch JS et al., - Kidney Int. 2020.

This study showed that 36.3% of patients hospitalized with COVID-19 developed acute kidney injury during hospitalization.

Covid-19